ANALYSIS OF IMMUNOREGULATORY DEFECT IN MRL/LPR MICE
MRL/LPR 小鼠免疫调节缺陷分析
基本信息
- 批准号:3071304
- 负责人:
- 金额:$ 6.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-01-01 至 1991-12-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte T lymphocyte antiantibody antibody formation autoantibody autoimmune disorder autoradiography bone marrow transplantation cell transformation clone cells enzyme linked immunosorbent assay flow cytometry graft versus host disease hematopoietic stem cells histocompatibility antigens hybridomas immunogenetics immunoglobulin G immunoregulation interleukin 2 interleukin 3 leukocyte activation /transformation leukocyte disorder leukopoiesis mixed lymphocyte reaction test monoclonal antibody nephritis newborn animals radiation immunosuppression radioimmunoassay receptor rheumatoid factor spleen transplantation splenectomy systemic lupus erythematosus tissue mosaicism
项目摘要
MRL/1 mice have an unusal stem cell defect that can manifest
itself, depending on conditions, in either a lymphoproliferative
lupus-like syndrome or in a runting graft-versus-host syndrome.
Autoimmunity is associated with production of many auto-
antibody specificities including exceptionally high titers of anti-
IgG antibody, referred to as rheumatoid factors (RF). The
proposed study addressed 4 main questions pertaining to the
MRL/1 model: 1) What factors are necessary are sufficent for the
massive T cell lymphoproliferation characteristic of MRL/1 mice
and how does this autoimmune environment affect the
differentiation of normal stem cells; 2) What are the target and
effector cells involved in the MRL/1 runting syndrome; 3) What
elicits RF production in MRL/1 mice and how do RF regulate
other B cells and influence disease progression; and 4) What is the
role of somatic muation in the generation of autoantibodies?
To approach these issues, "autoimmune x normal" chimeric mice
will be produced in which a mixture of phenotypically distinct
normal and autoimmune stem cells mature together in various
kinds of autoimmune environments. B cell activity will be
monitored by measuring serum Ig and autoantibody titers. T cell
functional activity will be measured in limiting dilution cultures.
The RF studies will involve the production and analysis of
monoclonal RF derived from MRL/1 and MRL/1 backcross mice.
Somatic mutation will be assessed by determining the rate and
direction of diversification of a particular germline gene
following antigen stimulation in an autoimmune environment.
Overall these studies should contribute to our basic understanding
of immunoregulatory pathways. The results of this proposal
should eventually have clinical application with regard to the
control of autoimmune disorders such as systemic lupus
erythematosus and rheumatoid arthritis as well as certain forms
of graft-versus-host disease.
MRL/1小鼠有一种不寻常的干细胞缺陷,可以表现出来
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autoantibody in MRL/Mp-lpr/lpr mice. A monoclonal antibody specific for the abnormal T cells from mice bearing the lpr/lpr gene.
MRL/Mp-lpr/lpr 小鼠中的自身抗体。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Yamada,K;Spezialetti,R;Marshak-Rothstein,A;Sy,MS
- 通讯作者:Sy,MS
Resistance to lymphoid engraftment in lpr recipients of normal bone marrow: characterization of chimeric stem cell, monocyte and peripheral lymphoid lineages.
正常骨髓 lpr 受体对淋巴移植的抵抗力:嵌合干细胞、单核细胞和外周淋巴谱系的特征。
- DOI:10.1002/eji.1830200908
- 发表时间:1990
- 期刊:
- 影响因子:5.4
- 作者:Glaser,RM;Marshak-Rothstein,A
- 通讯作者:Marshak-Rothstein,A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Marshak-Rothstein其他文献
Ann Marshak-Rothstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann Marshak-Rothstein', 18)}}的其他基金
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
TLR、II 型 IFN 和 III 型 IFN 在小鼠自身炎症模型中的作用
- 批准号:
10576930 - 财政年份:2021
- 资助金额:
$ 6.6万 - 项目类别:
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
TLR、II 型 IFN 和 III 型 IFN 在小鼠自身炎症模型中的作用
- 批准号:
10375346 - 财政年份:2021
- 资助金额:
$ 6.6万 - 项目类别:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
TLR9 缺陷和 FasL 促进皮肤狼疮的机制
- 批准号:
9752064 - 财政年份:2019
- 资助金额:
$ 6.6万 - 项目类别:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
TLR9 缺陷和 FasL 促进皮肤狼疮的机制
- 批准号:
9884735 - 财政年份:2019
- 资助金额:
$ 6.6万 - 项目类别:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
BCR/TLR7 和 BCR/TLR9 共同参与的不同功能结果
- 批准号:
9228925 - 财政年份:2015
- 资助金额:
$ 6.6万 - 项目类别:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
BCR/TLR7 和 BCR/TLR9 共同参与的不同功能结果
- 批准号:
9033830 - 财政年份:2015
- 资助金额:
$ 6.6万 - 项目类别:
Activation of B Cells by Host Toll-Like Receptor Ligands
宿主 Toll 样受体配体激活 B 细胞
- 批准号:
8504902 - 财政年份:2013
- 资助金额:
$ 6.6万 - 项目类别:
Activation of B Cells by Host Toll-Like Receptor Ligands
宿主 Toll 样受体配体激活 B 细胞
- 批准号:
8378438 - 财政年份:2012
- 资助金额:
$ 6.6万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 6.6万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 6.6万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 6.6万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




